Aneurysm Therapy Market
Aneurysm Therapy Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Aneurysm Therapy Market Size and Growth
The Aneurysm Therapy market is experiencing significant growth, driven by advancements in vascular intervention technologies and increased awareness of vascular diseases. The market is projected to reach approximately $4 billion by 2028, fueled by rising incidences of aneurysms and a growing demand for minimally invasive treatment options.
Companies Covered
(Covid 19 Impact Covered)
◍ Integra Life Sciences Corporation
◍ Medtronic Plc.
◍ Terumo Corporation (Micro Vention)
◍ MicroPort Medical Company
◍ Sequent Medical, Inc.
◍ Codman & Shurtleff
◍ Abbott, Boston Scientific
◍ phenox GmbH
◍ Pulsar Vascular, Inc.
The Aneurysm Therapy Market features key players like Integra Life Sciences, Medtronic, Terumo, and Abbott, focusing on innovative treatments and technologies. These companies enhance market growth through advanced product development and strategic partnerships.
Sales revenue highlights:
- Medtronic: $30 billion (2022)
- Abbott: $43 billion (2022)
- Boston Scientific: $11 billion (2022)
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
$ 403.00 Billion
Request Sample Report
